APDN:Applied DNA Sciences Inc Snapshot | Charting | News | Options
$2.75   0.00%  $0.00 NASDAQ 8:58a ET
May 13 '24 		Institute of Hematology and Blood Transfusion (Prague) to Present on Successful Use of Applied DNA's Linea... ACCESSWIRE
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story Top Stories on APDN
    No News Available
    Applied DNA Announces Second Quarter Fiscal Year 2024 Financial Resu...
    4:05p ET May 10 '24 ACCESSWIRE
    Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirem...
    9:22a ET May 10 '24 ACCESSWIRE
    Applied DNA Announces 1-For-20 Reverse Stock Split
    4:06p ET April 22 '24 ACCESSWIRE
    Applied DNA Enters into Agreement with Alphazyme for Scale-Up Manufac...
    9:02a ET March 18 '24 ACCESSWIRE
    Applied DNA to Showcase Linea(TM) DNA and Linea(TM) IVT Platforms at ...
    10:01a ET March 14 '24 ACCESSWIRE

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2024 All rights reserved.